Canada_IPAP - Anglo-Canadian Collaboration on Antimicrobial resistance

抗菌素耐药性（AMR）是一个主要的公共卫生问题，因为抗生素耐药细菌的增殖日益降低了我们最广泛使用的抗生素在治疗细菌性疾病中的有效性。当前的生物科学革命正在创造新的工具，这些工具提供了解决环境中的抗菌素耐药性问题的机会，并为针对抗菌素耐药性问题的新应用领域创造了“面向未来”的技术。成功的开发取决于对基础科学的进一步理解与在现场应用和部署实时监测的能力相结合，以更好地了解抗菌素耐药性在环境中的出现和传播。因此，英加抗菌素耐药性合作（ACCAMAR）旨在加强那些在微生物基因组学、代谢能力和社区互动方面工作的前沿人员之间的联系；以及那些设计下一代环境保护技术和人类风险暴露和缓解措施的人。

Antimicrobial resistance (AMR) is a major public health concern as the proliferation of antibiotic-resistant bacteria increasingly reduces the effectiveness of our most widely used antibiotics in the treatment of bacterial diseases. The current revolution in biosciences is creating new tools that offer the chance to tackle AMR issues in the environment and create 'future-proof' technologies for new areas of application, targeting AMR issues. Successful exploitation depends on combining an enhanced understanding of the fundamental science with an ability to apply and deploy in the field for real-time monitoring to better understand the emergence and dissemination of AMR in the environment. The Anglo-Canadian Collaboration on Antimicrobial resistance (ACCAMAR) thus aims to strengthen the links between those working at the forefront of microbial genomics, metabolic capabilities, and community interactions; and those designing next-generation environmental protection technologies and human risk exposure and mitigations.